What causes influenza to progress to pneumonia? That’s a question many healthy adults don’t ask because you can usually count on your immune system to defeat the flu virus. Yes, you’ll have to endure ...

Aug. 6, 2024 — An AI-based analysis of over 2 million hospital visits has found that most of the time, a pneumonia diagnosis made in the hospital will change from a patient's entrance to their ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

We also intervened in other CDC evidence-based practices for prevention of ventilator associated pneumonia [3] including ... a suggestive Gram's stain, and grow of bacteria (not necessarily ...

Symptoms associated with pneumonia were documented at baseline and at follow-up visits. A general assessment was given and the number of days until improvement/cure were recorded by the attending ...

A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...